Logo-npj
Submitted: 14 Apr 2017
Accepted: 23 Aug 2017
ePublished: 30 Nov 2017
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2018;7(1): 3-5.
doi: 10.15171/npj.2018.02
  Abstract View: 9931
  PDF Download: 4429

Editorial

Future directions in the treatment of BK virus nephropathy

Wisit Cheungpasitporn 1*, Charat Thongprayoon 2, Supavit Chesdachai 3,4, Jackrapong Bruminhent 4

1 Department of Internal Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi, USA
2 Department of Internal Medicine, Bassett Medical Center, Cooperstown, NY, USA
3 Department of Medicine, University of Minnesota, Minnesota, USA
4 Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand
*Corresponding Author: *Corresponding author: Wisit Cheungpasitporn MD, Email: , Email: wcheungpasitporn@gmail.com

Implication for health policy/practice/research/medical education:

BK polyomavirus-associated nephropathy (BKVAN) is an important cause of allograft renal dysfunction after kidney transplantation. Recent evidence has suggested associations of BK infection with urological malignancies and the development of de novo donor specific antibody (DSA). Despite recent advances in kidney transplantation knowledges, management of BKVAN has remained challenges. Recent evidence has suggested that BK-specific T-cell responses, but not neutralizing antibodies, is important in clearance of BK viremia. In this article, we present future directions in prevention and treatment of BKVAN.

Please cite this paper as: Cheungpasitporn W, Thongprayoon C, Chesdachai S, Bruminhent J. Future directions in the treatment of BK virus nephropathy. J Nephropharmacol. 2018;7(1):3-5. DOI: 10.15171/npj.2018.02. 

 

 

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 9932

Your browser does not support the canvas element.


PDF Download: 4429

Your browser does not support the canvas element.